Anthem Biosciences Ltd.
•₹ 871.45-0.35%
2026-08-21
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Contract Manufacturing Development & Discovery Services (CRDMO): 82.8% • Speciality Ingredients: 17.2%
PROS
- Company is almost debt free
- Company has a healthy return on capital (ROCE) of 29.0%
- Company has a good return on equity (ROE) track record: 3 Years ROE 22.5%
- Company comfortably covers its interest (135.6x coverage)
- Institutional investors have been accumulating - FII+DII up 11.0pp
- Company generates healthy free cash flow
CONS
- Promoter holding has decreased over last 2 years: -12.6pp
- Stock is trading at 11.7x its book value
- Operating margins have contracted to 39.6% from 48.1%
- Expensive relative to growth - PEG of 2.7
- Rich enterprise valuation - EV/EBITDA of 35.5x
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | ANTHEM | 881.75 | 86.26 | 49678.50 | 0.23 | 1199.41 | 783.28 | 4182.18 | 674.18 | 29.62 | 36.00 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| 339 | 525 | 498 | 479 | 538 | 552 | 417 | 582 | 384 | |
| 215 | 324 | 331 | 281 | 343 | 327 | 254 | 316 | 276 | |
| Operating Profit | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — |
| Other Income | 19 | 28 | 24 | 38 | 28 | 54 | 40 | 61 | 29 |
| Interest | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 1 |
| Depreciation | 18 | 19 | 20 | 21 | 23 | 24 | 27 | 26 | 22 |
| 122 | 207 | 170 | 213 | 199 | 253 | 150 | 301 | 136 | |
| Tax % | 29.88% | 17.72% | 24.67% | 42.42% | 25.43% | 21.66% | 25.30% | 29.62% | 25.19% |
| Net Profit | 85 | 170 | 128 | 123 | 148 | 198 | 112 | 212 | 102 |
| 2 | 3 | 2 | 2 | 3 | 4 | 2 | 4 | 0 | |
| Equity Capital | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 113 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 112 | 113 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2024
- 339
- 215
- Operating Profit
- —
- OPM %
- —
- Other Income
- 19
- Interest
- 3
- Depreciation
- 18
- 122
- Tax %
- 29.88%
- Net Profit
- 85
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 525
- 324
- Operating Profit
- —
- OPM %
- —
- Other Income
- 28
- Interest
- 3
- Depreciation
- 19
- 207
- Tax %
- 17.72%
- Net Profit
- 170
- 3
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 498
- 331
- Operating Profit
- —
- OPM %
- —
- Other Income
- 24
- Interest
- 2
- Depreciation
- 20
- 170
- Tax %
- 24.67%
- Net Profit
- 128
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 479
- 281
- Operating Profit
- —
- OPM %
- —
- Other Income
- 38
- Interest
- 2
- Depreciation
- 21
- 213
- Tax %
- 42.42%
- Net Profit
- 123
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 538
- 343
- Operating Profit
- —
- OPM %
- —
- Other Income
- 28
- Interest
- 2
- Depreciation
- 23
- 199
- Tax %
- 25.43%
- Net Profit
- 148
- 3
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 552
- 327
- Operating Profit
- —
- OPM %
- —
- Other Income
- 54
- Interest
- 2
- Depreciation
- 24
- 253
- Tax %
- 21.66%
- Net Profit
- 198
- 4
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 417
- 254
- Operating Profit
- —
- OPM %
- —
- Other Income
- 40
- Interest
- 1
- Depreciation
- 27
- 150
- Tax %
- 25.30%
- Net Profit
- 112
- 2
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 582
- 316
- Operating Profit
- —
- OPM %
- —
- Other Income
- 61
- Interest
- 2
- Depreciation
- 26
- 301
- Tax %
- 29.62%
- Net Profit
- 212
- 4
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 112
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 384
- 276
- Operating Profit
- —
- OPM %
- —
- Other Income
- 29
- Interest
- 1
- Depreciation
- 22
- 136
- Tax %
- 25.19%
- Net Profit
- 102
- 0
- Equity Capital
- 113
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 113
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 357 | 462 | 626 | 633 | 1,103 | 1,231 | 1,057 | 1,418 | 1,841 | 2,089 | 1,935 | |
| 248 | 341 | 454 | 451 | 695 | 664 | 634 | 913 | 1,151 | 1,238 | 1,172 | |
| Operating Profit | 115 | 131 | 192 | 203 | 445 | 617 | 508 | 576 | 799 | 1,033 | — |
| OPM % | 32 | 28 | 31 | 32 | 40 | 50 | 48 | 41 | 43 | 49 | — |
| Other Income | 6 | 10 | 21 | 21 | 37 | 49 | 85 | 71 | 109 | 182 | 183 |
| Interest | 5 | 18 | 18 | 20 | 17 | 12 | 9 | 9 | 9 | 7 | 6 |
| Depreciation | 22 | 53 | 61 | 62 | 62 | 58 | 64 | 81 | 78 | 100 | 99 |
| 88 | 60 | 114 | 121 | 366 | 547 | 498 | 485 | 711 | 903 | 840 | |
| Tax % | 25 | 41 | 32 | 23 | 26 | 26 | 23 | 23 | 29 | 26 | 26 |
| Net Profit | 66 | 36 | 77 | 93 | 271 | 406 | 386 | 375 | 506 | 671 | 624 |
| EPS | 79 | 43 | 91 | 108 | 323 | 463 | 7 | 6 | 9 | 12 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 1 | 2 | 5 | 7 | 7 | 6 | 9 | 12 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 1 | 1 | 1 | 2 | 5 | 7 | 7 | 6 | 9 | 12 | — |
Mar 2017
- 357
- 248
- Operating Profit
- 115
- OPM %
- 32
- Other Income
- 6
- Interest
- 5
- Depreciation
- 22
- 88
- Tax %
- 25
- Net Profit
- 66
- EPS
- 79
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2018
- 462
- 341
- Operating Profit
- 131
- OPM %
- 28
- Other Income
- 10
- Interest
- 18
- Depreciation
- 53
- 60
- Tax %
- 41
- Net Profit
- 36
- EPS
- 43
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2019
- 626
- 454
- Operating Profit
- 192
- OPM %
- 31
- Other Income
- 21
- Interest
- 18
- Depreciation
- 61
- 114
- Tax %
- 32
- Net Profit
- 77
- EPS
- 91
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 1
Mar 2020
- 633
- 451
- Operating Profit
- 203
- OPM %
- 32
- Other Income
- 21
- Interest
- 20
- Depreciation
- 62
- 121
- Tax %
- 23
- Net Profit
- 93
- EPS
- 108
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 2
Mar 2021
- 1,103
- 695
- Operating Profit
- 445
- OPM %
- 40
- Other Income
- 37
- Interest
- 17
- Depreciation
- 62
- 366
- Tax %
- 26
- Net Profit
- 271
- EPS
- 323
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2022
- 1,231
- 664
- Operating Profit
- 617
- OPM %
- 50
- Other Income
- 49
- Interest
- 12
- Depreciation
- 58
- 547
- Tax %
- 26
- Net Profit
- 406
- EPS
- 463
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2023
- 1,057
- 634
- Operating Profit
- 508
- OPM %
- 48
- Other Income
- 85
- Interest
- 9
- Depreciation
- 64
- 498
- Tax %
- 23
- Net Profit
- 386
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 1,418
- 913
- Operating Profit
- 576
- OPM %
- 41
- Other Income
- 71
- Interest
- 9
- Depreciation
- 81
- 485
- Tax %
- 23
- Net Profit
- 375
- EPS
- 6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2025
- 1,841
- 1,151
- Operating Profit
- 799
- OPM %
- 43
- Other Income
- 109
- Interest
- 9
- Depreciation
- 78
- 711
- Tax %
- 29
- Net Profit
- 506
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2026
- 2,089
- 1,238
- Operating Profit
- 1,033
- OPM %
- 49
- Other Income
- 182
- Interest
- 7
- Depreciation
- 100
- 903
- Tax %
- 26
- Net Profit
- 671
- EPS
- 12
- Dividend Payout %
- 17
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 12
TTM
- 1,935
- 1,172
- Operating Profit
- —
- OPM %
- —
- Other Income
- 183
- Interest
- 6
- Depreciation
- 99
- 840
- Tax %
- 26
- Net Profit
- 624
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 26%
- 5 Years:
- 14%
- 3 Years:
- 26%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 32%
- 5 Years:
- 20%
- 3 Years:
- 20%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 4%
RETURN ON EQUITY
- 10 Years:
- 29%
- 5 Years:
- 26%
- 3 Years:
- 23%
- Last Year:
- 24%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 8 | 8 | 8 | 8 | 8 | 9 | 114 | 112 | 112 | 112 | |
| 209 | 244 | 323 | 413 | 693 | 1,347 | 1,628 | 1,821 | 2,327 | 3,039 | |
| 20 | 38 | 23 | 26 | 80 | 30 | 29 | 101 | 43 | 0 | |
| Trade Payables | 33 | 57 | 54 | 58 | 77 | 65 | 72 | 100 | 110 | 70 |
| 233 | 258 | 303 | 270 | 232 | 276 | 241 | 268 | 384 | 485 | |
| Total Liabilities | 504 | 606 | 711 | 776 | 1,091 | 1,726 | 2,083 | 2,403 | 2,976 | 3,707 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 252 | 324 | 316 | 306 | 361 | 329 | 449 | 478 | 624 | 613 | |
| Capital Work in Progress | 43 | 6 | 12 | 50 | 19 | 153 | 143 | 156 | 58 | 84 |
| 27 | 7 | 73 | 99 | 209 | 273 | 499 | 472 | 533 | 1,380 | |
| 58 | 83 | 92 | 125 | 35 | 58 | 129 | 211 | 339 | 119 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 490 | 448 | 573 | |
| Cash & Bank | 11 | 5 | 14 | 22 | 41 | 349 | 343 | 184 | 166 | 270 |
| 113 | 183 | 206 | 174 | 426 | 564 | 519 | 412 | 808 | 669 | |
| Total Assets | 504 | 606 | 711 | 776 | 1,091 | 1,726 | 2,083 | 2,403 | 2,976 | 3,707 |
| Total Debt | 191 | 241 | 192 | 159 | 100 | 35 | 114 | 167 | 109 | 47 |
| Net Working Capital | 68 | 75 | 124 | 156 | 331 | 874 | 1,167 | 1,143 | 1,124 | 1,403 |
| Contingent Liabilities | 13 | 3 | 3 | 12 | 18 | 6 | 226 | 250 | 54 | 89 |
| Book Value per Share | 259.01 | 301.75 | 395.27 | 503.43 | 826.76 | 1544.46 | 30.53 | 34.58 | 43.62 | 56.10 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 191 | 241 | 192 | 159 | 100 | 35 | 114 | 167 | 109 | 47 |
| Net Working Capital | 68 | 75 | 124 | 156 | 331 | 874 | 1,167 | 1,143 | 1,124 | 1,403 |
| Contingent Liabilities | 13 | 3 | 3 | 12 | 18 | 6 | 226 | 250 | 54 | 89 |
| Book Value per Share | 259.01 | 301.75 | 395.27 | 503.43 | 826.76 | 1544.46 | 30.53 | 34.58 | 43.62 | 56.10 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- 8
- 209
- 20
- Trade Payables
- 33
- 233
- Total Liabilities
- 504
- 252
- Capital Work in Progress
- 43
- 27
- 58
- 0
- Cash & Bank
- 11
- 113
- Total Assets
- 504
- Total Debt
- 191
- Net Working Capital
- 68
- Contingent Liabilities
- 13
- Book Value per Share
- 259.01
- Face Value
- 10.00
- Total Debt
- 191
- Net Working Capital
- 68
- Contingent Liabilities
- 13
- Book Value per Share
- 259.01
- Face Value
- 10.00
Mar 2018
- 8
- 244
- 38
- Trade Payables
- 57
- 258
- Total Liabilities
- 606
- 324
- Capital Work in Progress
- 6
- 7
- 83
- 0
- Cash & Bank
- 5
- 183
- Total Assets
- 606
- Total Debt
- 241
- Net Working Capital
- 75
- Contingent Liabilities
- 3
- Book Value per Share
- 301.75
- Face Value
- 10.00
- Total Debt
- 241
- Net Working Capital
- 75
- Contingent Liabilities
- 3
- Book Value per Share
- 301.75
- Face Value
- 10.00
Mar 2019
- 8
- 323
- 23
- Trade Payables
- 54
- 303
- Total Liabilities
- 711
- 316
- Capital Work in Progress
- 12
- 73
- 92
- 0
- Cash & Bank
- 14
- 206
- Total Assets
- 711
- Total Debt
- 192
- Net Working Capital
- 124
- Contingent Liabilities
- 3
- Book Value per Share
- 395.27
- Face Value
- 10.00
- Total Debt
- 192
- Net Working Capital
- 124
- Contingent Liabilities
- 3
- Book Value per Share
- 395.27
- Face Value
- 10.00
Mar 2020
- 8
- 413
- 26
- Trade Payables
- 58
- 270
- Total Liabilities
- 776
- 306
- Capital Work in Progress
- 50
- 99
- 125
- 0
- Cash & Bank
- 22
- 174
- Total Assets
- 776
- Total Debt
- 159
- Net Working Capital
- 156
- Contingent Liabilities
- 12
- Book Value per Share
- 503.43
- Face Value
- 10.00
- Total Debt
- 159
- Net Working Capital
- 156
- Contingent Liabilities
- 12
- Book Value per Share
- 503.43
- Face Value
- 10.00
Mar 2021
- 8
- 693
- 80
- Trade Payables
- 77
- 232
- Total Liabilities
- 1,091
- 361
- Capital Work in Progress
- 19
- 209
- 35
- 0
- Cash & Bank
- 41
- 426
- Total Assets
- 1,091
- Total Debt
- 100
- Net Working Capital
- 331
- Contingent Liabilities
- 18
- Book Value per Share
- 826.76
- Face Value
- 10.00
- Total Debt
- 100
- Net Working Capital
- 331
- Contingent Liabilities
- 18
- Book Value per Share
- 826.76
- Face Value
- 10.00
Mar 2022
- 9
- 1,347
- 30
- Trade Payables
- 65
- 276
- Total Liabilities
- 1,726
- 329
- Capital Work in Progress
- 153
- 273
- 58
- 0
- Cash & Bank
- 349
- 564
- Total Assets
- 1,726
- Total Debt
- 35
- Net Working Capital
- 874
- Contingent Liabilities
- 6
- Book Value per Share
- 1544.46
- Face Value
- 10.00
- Total Debt
- 35
- Net Working Capital
- 874
- Contingent Liabilities
- 6
- Book Value per Share
- 1544.46
- Face Value
- 10.00
Mar 2023
- 114
- 1,628
- 29
- Trade Payables
- 72
- 241
- Total Liabilities
- 2,083
- 449
- Capital Work in Progress
- 143
- 499
- 129
- 0
- Cash & Bank
- 343
- 519
- Total Assets
- 2,083
- Total Debt
- 114
- Net Working Capital
- 1,167
- Contingent Liabilities
- 226
- Book Value per Share
- 30.53
- Face Value
- 2.00
- Total Debt
- 114
- Net Working Capital
- 1,167
- Contingent Liabilities
- 226
- Book Value per Share
- 30.53
- Face Value
- 2.00
Mar 2024
- 112
- 1,821
- 101
- Trade Payables
- 100
- 268
- Total Liabilities
- 2,403
- 478
- Capital Work in Progress
- 156
- 472
- 211
- 490
- Cash & Bank
- 184
- 412
- Total Assets
- 2,403
- Total Debt
- 167
- Net Working Capital
- 1,143
- Contingent Liabilities
- 250
- Book Value per Share
- 34.58
- Face Value
- 2.00
- Total Debt
- 167
- Net Working Capital
- 1,143
- Contingent Liabilities
- 250
- Book Value per Share
- 34.58
- Face Value
- 2.00
Mar 2025
- 112
- 2,327
- 43
- Trade Payables
- 110
- 384
- Total Liabilities
- 2,976
- 624
- Capital Work in Progress
- 58
- 533
- 339
- 448
- Cash & Bank
- 166
- 808
- Total Assets
- 2,976
- Total Debt
- 109
- Net Working Capital
- 1,124
- Contingent Liabilities
- 54
- Book Value per Share
- 43.62
- Face Value
- 2.00
- Total Debt
- 109
- Net Working Capital
- 1,124
- Contingent Liabilities
- 54
- Book Value per Share
- 43.62
- Face Value
- 2.00
Mar 2026
- 112
- 3,039
- 0
- Trade Payables
- 70
- 485
- Total Liabilities
- 3,707
- 613
- Capital Work in Progress
- 84
- 1,380
- 119
- 573
- Cash & Bank
- 270
- 669
- Total Assets
- 3,707
- Total Debt
- 47
- Net Working Capital
- 1,403
- Contingent Liabilities
- 89
- Book Value per Share
- 56.10
- Face Value
- 2.00
- Total Debt
- 47
- Net Working Capital
- 1,403
- Contingent Liabilities
- 89
- Book Value per Share
- 56.10
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 196 | 166 | 278 | 333 | 319 | 164 | 300 | 889 | |
| Cash from Investing | 0 | 0 | -121 | -109 | -196 | -206 | -378 | -192 | -249 | -742 |
| Cash from Financing | 0 | 0 | -65 | -48 | -63 | 181 | 53 | -132 | -68 | -44 |
| 0 | 0 | 9 | 9 | 18 | 308 | -6 | -159 | -17 | 104 | |
| Free Cash Flow | -179 | -87 | 138 | 77 | 193 | 175 | 151 | 45 | 183 | 781 |
| OCF / Net Profit | 0.00 | 0.00 | 2.55 | 1.79 | 1.02 | 0.82 | 0.83 | 0.44 | 0.59 | 1.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 142 | 496 | 734 | 641 | 746 | 1,334 |
| OCF / Net Profit | 0.00 | 0.00 | 2.55 | 1.79 | 1.02 | 0.82 | 0.83 | 0.44 | 0.59 | 1.33 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 142 | 496 | 734 | 641 | 746 | 1,334 |
Mar 2017
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -179
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
Mar 2018
- 0
- Cash from Investing
- 0
- Cash from Financing
- 0
- 0
- Free Cash Flow
- -87
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.00
- Cumulative 5-Year FCF
- 0
Mar 2019
- 196
- Cash from Investing
- -121
- Cash from Financing
- -65
- 9
- Free Cash Flow
- 138
- OCF / Net Profit
- 2.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.55
- Cumulative 5-Year FCF
- 0
Mar 2020
- 166
- Cash from Investing
- -109
- Cash from Financing
- -48
- 9
- Free Cash Flow
- 77
- OCF / Net Profit
- 1.79
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.79
- Cumulative 5-Year FCF
- 0
Mar 2021
- 278
- Cash from Investing
- -196
- Cash from Financing
- -63
- 18
- Free Cash Flow
- 193
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 142
- OCF / Net Profit
- 1.02
- Cumulative 5-Year FCF
- 142
Mar 2022
- 333
- Cash from Investing
- -206
- Cash from Financing
- 181
- 308
- Free Cash Flow
- 175
- OCF / Net Profit
- 0.82
- Cumulative 5-Year FCF
- 496
- OCF / Net Profit
- 0.82
- Cumulative 5-Year FCF
- 496
Mar 2023
- 319
- Cash from Investing
- -378
- Cash from Financing
- 53
- -6
- Free Cash Flow
- 151
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 734
- OCF / Net Profit
- 0.83
- Cumulative 5-Year FCF
- 734
Mar 2024
- 164
- Cash from Investing
- -192
- Cash from Financing
- -132
- -159
- Free Cash Flow
- 45
- OCF / Net Profit
- 0.44
- Cumulative 5-Year FCF
- 641
- OCF / Net Profit
- 0.44
- Cumulative 5-Year FCF
- 641
Mar 2025
- 300
- Cash from Investing
- -249
- Cash from Financing
- -68
- -17
- Free Cash Flow
- 183
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 746
- OCF / Net Profit
- 0.59
- Cumulative 5-Year FCF
- 746
Mar 2026
- 889
- Cash from Investing
- -742
- Cash from Financing
- -44
- 104
- Free Cash Flow
- 781
- OCF / Net Profit
- 1.33
- Cumulative 5-Year FCF
- 1,334
- OCF / Net Profit
- 1.33
- Cumulative 5-Year FCF
- 1,334
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 78.61 | 42.74 | 91.97 | 110.62 | 319.76 | 462.60 | 6.76 | 6.09 | 9.05 | 11.94 |
| Book Value (₹) | 259.01 | 301.75 | 395.27 | 503.43 | 826.76 | 1544.46 | 30.53 | 34.58 | 43.62 | 56.10 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 |
| Cash EPS (₹) | 1.61 | 1.63 | 2.53 | 2.83 | 6.05 | 8.13 | 7.88 | 8.16 | 10.45 | 13.71 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 32.28% | 28.36% | 30.74% | 32.03% | 40.35% | 50.07% | 48.10% | 35.63% | 37.32% | 39.63% |
| Net Margin % | 18.56% | 7.75% | 12.31% | 14.65% | 24.59% | 32.97% | 36.49% | 26.44% | 27.41% | 31.22% |
| ROE % | 39.11% | 15.24% | 26.39% | 24.62% | 48.30% | 39.48% | 24.91% | 20.40% | 23.16% | 23.99% |
| ROCE % | 29.42% | 17.24% | 25.87% | 25.56% | 55.39% | 50.97% | 31.20% | 24.98% | 30.79% | 31.30% |
| 16.64% | 6.45% | 11.70% | 12.47% | 29.07% | 28.82% | 20.25% | 16.71% | 18.82% | 20.07% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 63 | 77 | 70 | 64 | 60 | 86 | 104 | 98 | 93 | 87 |
| Inventory Days | 45 | 56 | 51 | 63 | 27 | 14 | 32 | 44 | 54 | 39 |
| Payable Days | 66 | 85 | 73 | 81 | 54 | 62 | 73 | 52 | 52 | 41 |
| 42 | 48 | 47 | 46 | 32 | 37 | 63 | 90 | 95 | 84 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.87x | 0.95x | 0.58x | 0.38x | 0.14x | 0.03x | 0.07x | 0.09x | 0.04x | 0.01x |
| Interest Coverage (x) | 17.24x | 4.40x | 7.25x | 6.91x | 22.32x | 45.85x | 58.14x | 53.32x | 77.61x | 135.63x |
| 1.54x | 1.43x | 1.51x | 1.63x | 1.93x | 3.53x | 5.36x | 3.71x | 3.50x | 3.87x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 70.48% | 29.61% | 35.48% | 1.07% | 74.36% | 11.60% | -14.16% | 34.12% | 29.85% | 13.51% |
| Operating Profit Growth % | 47.45% | 13.86% | 46.84% | 5.33% | 119.62% | 38.51% | -17.54% | 13.21% | 38.77% | 29.39% |
| Net Profit Growth % | 62.78% | -45.87% | 115.17% | 20.29% | 192.66% | 49.64% | -5.00% | -2.82% | 35.06% | 32.47% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -9.88% | 48.61% | 31.85% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 54.98x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 11.70x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.30% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.16x | 0.07x | 35.46x |
Mar 2017
- EPS (₹)
- 78.61
- Book Value (₹)
- 259.01
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.61
- Operating Margin %
- 32.28%
- Net Margin %
- 18.56%
- ROE %
- 39.11%
- ROCE %
- 29.42%
- 16.64%
- Debtor Days
- 63
- Inventory Days
- 45
- Payable Days
- 66
- 42
- Debt to Equity (x)
- 0.87x
- Interest Coverage (x)
- 17.24x
- 1.54x
- Revenue Growth %
- 70.48%
- Operating Profit Growth %
- 47.45%
- Net Profit Growth %
- 62.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 42.74
- Book Value (₹)
- 301.75
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 1.63
- Operating Margin %
- 28.36%
- Net Margin %
- 7.75%
- ROE %
- 15.24%
- ROCE %
- 17.24%
- 6.45%
- Debtor Days
- 77
- Inventory Days
- 56
- Payable Days
- 85
- 48
- Debt to Equity (x)
- 0.95x
- Interest Coverage (x)
- 4.40x
- 1.43x
- Revenue Growth %
- 29.61%
- Operating Profit Growth %
- 13.86%
- Net Profit Growth %
- -45.87%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 91.97
- Book Value (₹)
- 395.27
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.53
- Operating Margin %
- 30.74%
- Net Margin %
- 12.31%
- ROE %
- 26.39%
- ROCE %
- 25.87%
- 11.70%
- Debtor Days
- 70
- Inventory Days
- 51
- Payable Days
- 73
- 47
- Debt to Equity (x)
- 0.58x
- Interest Coverage (x)
- 7.25x
- 1.51x
- Revenue Growth %
- 35.48%
- Operating Profit Growth %
- 46.84%
- Net Profit Growth %
- 115.17%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 110.62
- Book Value (₹)
- 503.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 2.83
- Operating Margin %
- 32.03%
- Net Margin %
- 14.65%
- ROE %
- 24.62%
- ROCE %
- 25.56%
- 12.47%
- Debtor Days
- 64
- Inventory Days
- 63
- Payable Days
- 81
- 46
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 6.91x
- 1.63x
- Revenue Growth %
- 1.07%
- Operating Profit Growth %
- 5.33%
- Net Profit Growth %
- 20.29%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 319.76
- Book Value (₹)
- 826.76
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.05
- Operating Margin %
- 40.35%
- Net Margin %
- 24.59%
- ROE %
- 48.30%
- ROCE %
- 55.39%
- 29.07%
- Debtor Days
- 60
- Inventory Days
- 27
- Payable Days
- 54
- 32
- Debt to Equity (x)
- 0.14x
- Interest Coverage (x)
- 22.32x
- 1.93x
- Revenue Growth %
- 74.36%
- Operating Profit Growth %
- 119.62%
- Net Profit Growth %
- 192.66%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 462.60
- Book Value (₹)
- 1544.46
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.13
- Operating Margin %
- 50.07%
- Net Margin %
- 32.97%
- ROE %
- 39.48%
- ROCE %
- 50.97%
- 28.82%
- Debtor Days
- 86
- Inventory Days
- 14
- Payable Days
- 62
- 37
- Debt to Equity (x)
- 0.03x
- Interest Coverage (x)
- 45.85x
- 3.53x
- Revenue Growth %
- 11.60%
- Operating Profit Growth %
- 38.51%
- Net Profit Growth %
- 49.64%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.76
- Book Value (₹)
- 30.53
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.88
- Operating Margin %
- 48.10%
- Net Margin %
- 36.49%
- ROE %
- 24.91%
- ROCE %
- 31.20%
- 20.25%
- Debtor Days
- 104
- Inventory Days
- 32
- Payable Days
- 73
- 63
- Debt to Equity (x)
- 0.07x
- Interest Coverage (x)
- 58.14x
- 5.36x
- Revenue Growth %
- -14.16%
- Operating Profit Growth %
- -17.54%
- Net Profit Growth %
- -5.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 6.09
- Book Value (₹)
- 34.58
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.16
- Operating Margin %
- 35.63%
- Net Margin %
- 26.44%
- ROE %
- 20.40%
- ROCE %
- 24.98%
- 16.71%
- Debtor Days
- 98
- Inventory Days
- 44
- Payable Days
- 52
- 90
- Debt to Equity (x)
- 0.09x
- Interest Coverage (x)
- 53.32x
- 3.71x
- Revenue Growth %
- 34.12%
- Operating Profit Growth %
- 13.21%
- Net Profit Growth %
- -2.82%
- -9.88%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.16x
Mar 2025
- EPS (₹)
- 9.05
- Book Value (₹)
- 43.62
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.45
- Operating Margin %
- 37.32%
- Net Margin %
- 27.41%
- ROE %
- 23.16%
- ROCE %
- 30.79%
- 18.82%
- Debtor Days
- 93
- Inventory Days
- 54
- Payable Days
- 52
- 95
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 77.61x
- 3.50x
- Revenue Growth %
- 29.85%
- Operating Profit Growth %
- 38.77%
- Net Profit Growth %
- 35.06%
- 48.61%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.07x
Mar 2026
- EPS (₹)
- 11.94
- Book Value (₹)
- 56.10
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 13.71
- Operating Margin %
- 39.63%
- Net Margin %
- 31.22%
- ROE %
- 23.99%
- ROCE %
- 31.30%
- 20.07%
- Debtor Days
- 87
- Inventory Days
- 39
- Payable Days
- 41
- 84
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 135.63x
- 3.87x
- Revenue Growth %
- 13.51%
- Operating Profit Growth %
- 29.39%
- Net Profit Growth %
- 32.47%
- 31.85%
- P/E (x)
- 54.98x
- P/B (x)
- 11.70x
- Dividend Yield %
- 0.30%
- 35.46x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-07-27 - Anthem Biosciences Limited has informed the Exchange about Transcript
- Shareholders meeting
2026-07-24 - Anthem Biosciences Limited has submitted the Exchange the voting results and a copy Srutinizers report of the 20th Annual General Meeting held on July 22, 2026.
Annual Reports
Nothing filed yet.
Credit Ratings
- Credit Rating
2026-07-03 - Anthem Biosciences Limited has informed the Exchange about Credit Rating
Concalls
Jul 2026
May 2026
Feb 2026